Pelthos Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $24.2M | $32.0M | $18.0M | $14.2M | $59.0K | $131.0K | $513.0K | $1.3M |
| Accounts Receivable | $14.5M | $11.7M | $8.9M | — | — | — | $0 | — |
| Inventory | $21.5M | $23.4M | $23.6M | $24.1M | — | — | $0 | — |
| Total Current Assets | $63.4M | $69.8M | $53.4M | $49.8M | $822.9K | $911.2K | $1.4M | $2.1M |
| Property, Plant & Equipment | $8.9M | $9.3M | $9.6M | $10.2M | — | — | $0 | — |
| Goodwill | $24.7M | $24.7M | $24.7M | $30.6M | — | — | $0 | — |
| Intangible Assets (Excl. Goodwill) | $37.4M | $38.4M | $39.5M | $32.5M | — | — | $0 | — |
| Total Assets | $137.4M | $145.4M | $130.4M | $126.4M | $822.9K | $911.2K | $1.4M | $2.1M |
| Liabilities | ||||||||
| Accounts Payable | $5.9M | $6.1M | $3.0M | $5.7M | — | — | $1.9M | — |
| Total Current Liabilities | $32.0M | $25.0M | $26.0M | $24.8M | $7.3M | $5.1M | $4.1M | $3.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $138.9M | $126.1M | $91.5M | $68.2M | $7.3M | $5.1M | $4.1M | $3.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-113.3M | $-89.9M | $-64.8M | $-43.1M | $-26.9M | $-23.4M | $-21.5M | $-19.5M |
| Total Stockholders' Equity | $-1.5M | $19.3M | $38.9M | $58.3M | $-6.5M | $-4.2M | $-2.7M | $-1.4M |